SuperworthStoke Therapeutics shares outstanding STOK
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 66M
- On a year earlier
- +13.1%
- more shares
Stoke Therapeutics had 66M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 13.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 62M | +9% |
| FY2024 | 57M | +27% |
| FY2023 | 45M | +14% |
| FY2022 | 39.4M | +7% |
| FY2021 | 36.8M | +5% |
| FY2020 | 35.1M | +7% |
| FY2019 | 32.7M | +4213% |
| FY2018 | 759.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 66M | +13% | |
| Q1 FY26 | 63.1M | +6% | |
| Q4 FY25 | 62M | +9% | |
| Q3 FY25 | 58.6M | +4% | |
| Q2 FY25 | 58.4M | +5% | |
| Q1 FY25 | 59.4M | +28% | |
| Q4 FY24 | 57M | +27% | |
| Q3 FY24 | 56.3M | +27% | |
| Q2 FY24 | 55.8M | +26% | |
| Q1 FY24 | 46.2M | +9% | |
| Q4 FY23 | 45M | +14% | |
| Q3 FY23 | 44.3M | +12% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Stoke Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.